- Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells2013 | First Faculty of Medicine, Third Faculty of Medicine
- Cerebellar demyelination and neurodegeneration associated with mTORC1 hyperactivity may contribute to the developmental onset of autism-like neurobehavioral phenotype in a rat model2022 | Third Faculty of Medicine, Central Library of Charles University
- Involvement of c-Src activity in the mTOR-dependent oncogenicity of melanoma cellsPublication without faculty affiliation
- Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells2008 | First Faculty of Medicine
- Developmental effects of constitutive mTORC1 hyperactivity and environmental enrichment on structural synaptic plasticity and behaviour in a rat model of autism spectrum disorder2023 | First Faculty of Medicine, Faculty of Science, Central Library of Charles University
- Activity of c-Src as a novel target for the inhibition of mTOR signaling in human diseasesPublication without faculty affiliation
- The landscape of epilepsy-related GATOR1 variants2019 | Second Faculty of Medicine
- A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development2023 | Faculty of Science
- Integrated actions of mTOR complexes 1 and 2 for growth and development of Dictyostelium2019 | Faculty of Science
- MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis2021 | Second Faculty of Medicine
- The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas2020 | Second Faculty of Medicine
- Involvement of mTOR Pathways in Recovery from Spinal Cord Injury by Modulation of Autophagy and Immune Response2021 | Second Faculty of Medicine
- Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)2022 | Publication without faculty affiliation
- Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes2021 | Third Faculty of Medicine
- The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury2023 | Second Faculty of Medicine
- Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics2022 | Faculty of Medicine in Hradec Králové
- TSC/mTOR pathway mutation associated eosinophilic/oncocytic renal neoplasmsm: a heterogeneous group of tumors with distinct morhpology, immunohistochemical profile, and similar genetic background2022 | Faculty of Medicine in Pilsen
- mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis2022 | First Faculty of Medicine
- Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8(+) T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness2019 | Second Faculty of Medicine
- Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge2020 | Second Faculty of Medicine
- Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment2017 | Second Faculty of Medicine
- Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex2016 | Second Faculty of Medicine